Placemark Investments’s Gilead Sciences GILD Stock Holding History

Placemark Investments’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$26.9M	Sell	285,251 -20,746	-7%	-$2.15M	0.48%	28
2014 Q3	$32.6M	Sell	305,997 -13,202	-4%	-$1.29M	0.6%	17
2014 Q2	$26.5M	Sell	319,199 -53,439	-14%	-$4.16M	0.47%	34
2014 Q1	$26.4M	Buy	372,638 +6,878	+2%	+$539K	0.5%	23
2013 Q4	$27.5M	Buy	365,760 +14,710	+4%	+$1.02M	0.45%	36
2013 Q3	$22.1M	Buy	351,050 +47,957	+16%	+$2.87M	0.42%	45
2013 Q2	$15.5M	Buy	+303,093	New	+$15.8M	0.33%	61

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Placemark Investments's GILD Position: Q4 2014 in Review

Placemark Investments reduced its Gilead Sciences (GILD) stake by 6.8% in Q4 2014, selling an estimated $2.15M and leaving 285,251 shares worth $26.9M. The position accounts for 0.48% of the portfolio, ranked #28.

Placemark Investments first reported a position in GILD in Q2 2013 and has held it in 7 quarters since. The position peaked at $32.6M in Q3 2014. 1,438 funds tracked by Wall St. Rank hold GILD as of Q4 2014.

Placemark Investments held 285,251 shares of Gilead Sciences worth $26.9M as of Q4 2014.
Placemark Investments sold 20,746 Gilead Sciences shares in Q4 2014, an estimated $2.15M.
Gilead Sciences made up 0.48% of Placemark Investments's portfolio in Q4 2014, its #28 holding.
Placemark Investments first reported a position in Gilead Sciences in Q2 2013 and has held it in 7 quarters since.
Placemark Investments's Gilead Sciences position peaked at $32.6M in Q3 2014.
1,438 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.